If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Paolo Pronzato is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 97 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Biosimilar pegfilgrastim and adherence to guidelines for chemotherapy-induced neutropenia and infections in cancer patients

Danova, M., Antonuzzo, A., Spandonaro, F. & Pronzato, P., Mar 1 2020, In : Le infezioni in medicina. 28, 1, p. 127-129 3 p.

Research output: Contribution to journalArticle

  • Endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: extending endocrine sensitivity

    Frassoldati, A., Biganzoli, L., Bordonaro, R., Cinieri, S., Conte, P., Laurentis, M. D., Mastro, L. D., Gori, S., Lauria, R., Marchetti, P., Michelotti, A., Montemurro, F., Naso, G., Pronzato, P., Puglisi, F. & Tondini, C. A., Feb 1 2020, In : Future Oncology. 16, 5, p. 129-145 17 p.

    Research output: Contribution to journalArticle

  • Endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: extending endocrine sensitivity

    Frassoldati, A., Biganzoli, L., Bordonaro, R., Cinieri, S., Conte, P., Laurentis, M. D., Mastro, L. D., Gori, S., Lauria, R., Marchetti, P., Michelotti, A., Montemurro, F., Naso, G., Pronzato, P., Puglisi, F. & Tondini, C. A., Feb 1 2020, In : Future oncology (London, England). 16, 5, p. 129-145 17 p.

    Research output: Contribution to journalArticle

  • Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies

    Cazzaniga, M. E., Verusio, C., Ciccarese, M., Fumagalli, A., Sartori, D., Valerio, M. R., Airoldi, M., Moretti, G., Ficorella, C., Gianni, L., Michelotti, A., Zambelli, A., Febbraro, A., Generali, D., Pistelli, M., Garrone, O., Musolino, A., Vici, P., Maur, M., Mentuccia, L. & 31 others, La Verde, N., Bianchi, G. V., Artale, S., Blasi, L., De Laurentiis, M., Atzori, F., Turletti, A., Porpiglia, M., Santini, D., Fabi, A., Gebbia, V., Schirone, A., Palumbo, R., Ferzi, A., Frassoldati, A., Scavelli, C., Clivio, L., Giordano, M., Donadio, M., Biganzoli, L., Del Mastro, L., Bisagni, G., Livi, L., Natoli, C., Montemurro, F., Riccardi, F., Romagnoli, E., Marchetti, P., Torri, V., Pronzato, P. & Mustacchi, G., Jan 1 2020, In : Breast Care. 15, p. 30-37 8 p.

    Research output: Contribution to journalArticle

  • Precision medicine for NSCLC in the era of immunotherapy: New biomarkers to select the most suitable treatment or the most suitable patient

    Rossi, G., Russo, A., Tagliamento, M., Tuzi, A., Nigro, O., Vallome, G., Sini, C., Grassi, M., Dal Bello, M. G., Coco, S., Longo, L., Zullo, L., Tanda, E. T., Dellepiane, C., Pronzato, P. & Genova, C., May 2020, In : Cancers. 12, 5, 1125.

    Research output: Contribution to journalReview article

    Open Access